Texas · 88188

Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers in Texas

Texas Medicare Avg
$46.85
3% below national avg
National Medicare Avg
$48.39
All states combined
Billed Charge (TX)
$779.88
What providers submit
Est. Commercial (TX)
$140.47
National avg: $138.37
Est. Cash / Self-Pay (TX)
$260.27
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

3.3K
Services in TX
197
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Texas

Provider Medicare Services
Thakral, Beenu M.D. $46.87 97
Neogenomics Laboratories Inc $49.57 59
Propath Services, Llc $46.48 40
Ameripath Texas, Inc. $48.69 33
Neogenomics Laboratories Inc $48.02 32
Inform Diagnostics, Inc $47.87 30
Neogenomics Laboratories Inc $49.57 30
Pathology Associates Of Tyler Pa $45.48 27
Ameripath Lubbock 5.01(A)... $48.34 22
Shuai, Wen $46.85 20
Pathology Reference Laboratory,... $45.68 13

Texas Pricing in Context

In Texas, CPT code 88188 (Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers) carries an average Medicare payment of $46.85 — 3% below the national benchmark of $48.39. 197 providers across the state submitted claims for this procedure in 2023, performing 3.3K total services. Individual payments in TX ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Texas is $779.88, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Texas sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Genetic/Molecular Test procedures, the estimated commercial insurance price in Texas lands near $140.47, with self-pay cash prices typically around $260.27. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers cost in Texas?

The average Medicare payment for Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers in Texas is $46.85, which is 3% below the national average of $48.39. Providers in TX typically bill $779.88 for this procedure.

What does Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers cost with insurance in Texas?

With commercial insurance in Texas, Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers costs an estimated $140.47. Without insurance, the estimated cash price is $260.27. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers in Texas?

197 providers in Texas billed Medicare for Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers in 2023, performing 3.3K total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers cheaper in Texas than the national average?

Yes — Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers costs 3% below the national average in Texas. The state average Medicare payment is $46.85 compared to $48.39 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial